# An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

> **NCT04943042** · — · COMPLETED · sponsor: **Swedish Orphan Biovitrum** · enrollment: 199 (actual)

## Conditions studied

- Immune Thrombocytopenia
- ITP

## Interventions

- **DRUG:** Avatrombopag

## Key facts

- **NCT ID:** NCT04943042
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-22
- **Primary completion:** 2025-06-10
- **Final completion:** 2025-06-10
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2025-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04943042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04943042, "An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04943042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*